For a condition that affects nearly 15 percent of the world's population, there are remarkably few effective treatments for migraine sufferers. A new antibody treatment designed specifically for migraine prevention has just completed Phase III human clinical trials with remarkably positive results, raising hopes of a possible revolution on the horizon for sufferers of this debilitating condition.
.. Continue Reading Breakthrough migraine therapy cuts number of attacks in halfCategory: Medical
Tags: Related Articles:
- Positive results from antibody treatment in human Alzheimer's trial
- New asthma treatment pulls the problem out of the blood
- Scientists combine viruses and human antibodies to hunt down superbugs
- Human antibodies in Ebola survivor's blood effective against all strains
- Human antibody shown to impart forcefield-like qualities to placenta to battle Zika
- Human immune system proteins shown to suppress HIV
from New Atlas http://ift.tt/2zKjY8N
No comments:
Post a Comment